Experts share here what they take away from the Conference on Retroviruses and Opportunistic Infections (CROI) each year and why this meeting is so important in this space. The combination of ...

Semaglutide stabilizes epigenetic ageing in people with HIV-associated lipohypertrophy. Conference on Retroviruses and Opportunistic Infections, San Francisco, abstract 181, 2025. View the abstract on ...

Two new ways of giving the HIV medicine Dolutegravir to newborn babies have been found to be safe and effective, according to ...

In a first-ever milestone, Africa’s initial HIV cure trial has yielded historic findings: 20% of patients have remained off ...

The following content was published by The Lancet Group and presented at the most recent Conference on Retroviruses and Opportunistic Infections. Don’t miss our content presented at upcoming ...

Research led by Professor Adrie Bekker is paving the way for an important HIV medicine to be made available to neonates in a way that is both safe and much more convenient than previous options.

The study’s findings were presented at the Conference on Retroviruses and Opportunistic Infections in March. Researchers are currently writing up the final results of the study for publication ...

The study's findings were presented at the Conference on Retroviruses and Opportunistic Infections in March. Researchers are currently writing up the final results of the study for publication in ...

The data were presented during an oral abstract session at the Conference on Retroviruses and Opportunistic Infections (CROI 2025) and were also published today in The FOSTER CITY, Calif., ...

An investigator-led study reported at the recent Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle, involving at-risk gay and bisexual men, found there was a 50% reduction ...